LMNA & EDMD​

• Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes, Shah, 2021

• Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome', Bonne, 2021

• Partial Lipodystrophy and LMNA p.R545H Variant, Magno, 2021

• Establishment of an iPSC line (JSPHi001-A) from a patient with familial dilated cardiomyopathy and atrial fibrillation caused by LMNA missense mutation (c.1003C > T), Zhang, 2021

• Timing of pacemaker and ICD implantation in LMNA mutation carriers, Ollila, 2021

• A splicing LMNA mutation causing laminopathies accompanied by aortic valve malformation, Tao, 2021

• Ryanodine receptor remodeling in cardiomyopathy and muscular dystrophy caused by lamin A/C gene mutation, Dridi, 2021

• International retrospective natural history study of LMNA-related congenital muscular dystrophy, Yaou, 2021

• Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth, Owens, 2021

• Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene, Araújo-Vilar. 2021

• A lamin A/C variant causing striated muscle disease provides insights into filament organization, Kronenberg-Tenga, 2021

• Echocardiographic Features of Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy, Marchel, 2021

• Lamin A/C Assembly Defects in LMNA-Congenital Muscular Dystrophy Is Responsible for the Increased Severity of the Disease Compared with Emery-Dreifuss Muscular Dystrophy, Bertrand, 2020

• Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses, Zhou, 2020

• Consequences of Lmna Exon 4 Mutations in Myoblast Function, Gomez-Dominguez, 2020,

• Exercise is Associated With Impaired Left Ventricular Systolic Function in Patients With Lamin A/C Genotype, Skjolsvik, 2020

• Dropped head related lamin A/C associated congenital muscular dystrophy case; previously defined as emery dreifuss muscular dystrophy, Tekin, 2020

• Lamin A‐mediated nuclear lamina integrity is required for proper ciliogenesis, Fan, 2020

• Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy, Zhang, 2020

• Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth, Owens, 2020

• Using nuclear envelope mutations to explore age-related skeletal muscle weakness, Battey, 2020

• Exercise is Associated With Impaired Left Ventricular Systolic Function in Patients With Lamin A/C Genotype, Skjolsvik, 2020

• Need for NAD +: Focus on Striated Muscle Laminopathies, Cardoso, 2020

• Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells, Earle, 2020

• Relationship between infrared skin radiation and functional tests in patients affected by Emery-Dreifuss muscular dystrophy: Part 2, Cabizosu, 2020

• Protein Kinase C Alpha Cellular Distribution, Activity, and Proximity with Lamin A/C in Striated Muscle Laminopathie, Nicolas, 2020

• Nuclear lamin phosphorylation: an emerging role in gene regulation and pathogenesis of laminopathies, Liu, 2020

• Postnatal development of mice with combined genetic depletions of lamin A/C, emerin and lamina-associated polypeptide 1, Wang, 2020

• Nuclear lamin phosphorylation: an emerging role in gene regulation and pathogenesis of laminopathies, Liu, 2020

• Novel clinical features and pleiotropic effect in three unrelated patients with LMNA variant, Turkyilimaz, 2020

• Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses, Zhou, 2020

• Emery–Dreifuss muscular dystrophy: focal point nuclear envelope, Muchir, 2020

• Ventricular Tachycardia in a Patient With Dilated Cardiomyopathy Caused by a Novel Mutation of Lamin A/C Gene: Insights From Features on Electroanatomic Mapping, Catheter Ablation and Tissue Pathology, Bennett, 2020

• Lamin A‐mediated nuclear lamina integrity is required for proper ciliogenesis, Fan, 2020

• Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study, Peretto, 2020

• Case series: LMNA‐related dilated cardiomyopathy presents with reginal wall akinesis and transmural late gadolinium enhancement, Wang, 2020􀁆􀁄􀁖􀁈 􀁕􀁈􀁓􀁒􀁕􀁗 

• LMNA Mutations G232E and R482L Cause Dysregulation of Skeletal Muscle Differentiation, Bioenergetics, and Metabolic Gene Expression Profile, Ignatieva, 2020

• Distinct Cardiac Transcriptomic Clustering in Titin and Lamin A/C-Associated Dilated Cardiomyopathy Patients, Verdonschot, 2020

• Multisystem Progeroid Syndrome With Lipodystrophy, Cardiomyopathy, and Nephropathy Due to an LMNA p.R349W Variant, Hussain, 2020

• Familial dilated cardiomyopathy with a novel LMNA mutation (p.R429C): a case report, Li, 2020

• Identification of Genes and Pathways Regulated by Lamin A in Heart, Pradas, 2020

• Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses, Zhou, 2020

• A Novel EMD Mutation Identified by Whole-Exome Sequencing in Twins with Emery-Dreifuss Muscular Dystrophy, Dai, 2020

• Atypical Progeroid Syndrome and Partial Lipodystrophy Due to LMNA Gene p.R349W Mutation, Magno, 2020

• X-linked Emery-Dreifuss muscular dystrophy manifesting with adult onset axial weakness, camptocormia, and minimal joint contractures, Brisset, 2020

• Using nuclear envelope mutations to explore age-related skeletal muscle weakness, Battey, 2020

• The Molecular Basis and Biologic Significance of the β-Dystroglycan-Emerin Interaction, Gomez, 2020

• LMNA Missense Mutation Causes Nonsense-mediated mRNA Decay and Severe Dilated Cardiomyopathy, Kato 2020

• C-terminal mutations in SYNE1 are associated with motor neuron disease in patients with SCAR8, Kume, 2020

• Cardiovascular Involvement in Pediatric Laminopathies. Report of Six Patients and Literature Revision, Baban, 2020

• A very long-term observation of a family with dilated cardiomyopathy and overlapping phenotype from lamin A/C mutation, Porcu, 2020

• The Broad Spectrum of LMNA Cardiac Diseases: From Molecular Mechanisms to Clinical Phenotype, Castro, 2020

• Single Myofiber Isolation and Culture from a Murine Model of Emery-Dreifuss Muscular Dystrophy in Early Post-Natal Development, Pegoli, 2020

• Nuclear Factor-κB Pathway Mediates the Molecular Pathogenesis of LMNA-Related Muscular Dystrophies, Fan, 2020

• Gene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis, Widyastuti, 2020

• PCAF Involvement in Lamin A/C-HDAC2 Interplay during the Early Phase of Muscle Differentiation, Sanit, 2020

• An Omics View of Emery–Dreifuss Muscular Dystrophy, Vignier, 2020

• Deletion of entire LMNA gene as a cause of cardiomyopathy, Cirino, 2020

• Homozygous LMNA p.R582H pathogenic variant reveals increasing effect on the severity of fat loss in lipodystrophy, Soyaltin, 2020

• Case series: LMNA-related dilated cardiomyopathy presents with reginal wall akinesis and transmural late gadolinium enhancement, Wang, 2020

• Genotype-phenotype correlation of LMNA variants involving the Arg541 residue: a case report with multimodality imaging and literature review, Di Marco, 2020

• Generation of two iPSC lines (FAMRCi007-A and FAMRCi007-B) from patient with Emery-Dreifuss muscular dystrophy and heart rhythm abnormalities carrying genetic variant LMNA p.Arg249Gln, Perepelina, 2020

• Cytokine Profile in Striated Muscle Laminopathies: New Promising Biomarkers for Disease Prediction, Cappeletti, 2020

• Microtubule Cytoskeleton Regulates Connexin 43 Localization and Cardiac Conduction in Cardiomyopathy Caused by Mutation in A-type Lamins Gene, Macquart, 2020

• Atrial Arrhythmias in Emery-Dreifuss Muscular Dystrophy: Approach to Successful Ablation, Butt, 2020

• Clinical Spectrum and Genetic Variations of LMNA-related Muscular Dystrophies in a Large Cohort of Chinese Patients, Fan, 2020

• An Omics View of Emery-Dreifuss Muscular Dystrophy, Vignier, 2020

• EDMD-Causing Emerin Mutant Myogenic Progenitors Exhibit Impaired Differentiation Using Similar Mechanisms, Iyer, 2020

• Cardiac and Neuromuscular Features of Patients With LMNA-Related Cardiomyopathy, Peretto, 2020

• Emerin Phosphorylation During the Early Phase of the Oxidative Stress Response Influences Emerin-BAF Interaction and BAF Nuclear Localization, Cenni, 2020

• Muscle Cell Differentiation and Development Pathway Defects in Emery-Dreifuss Muscular Dystrophy, Storey, 2020

• Unusual Presentations of LMNA-Associated Lipodystrophy with Complex Phenotypes and Generalized Fat Loss When the Genetic Diagnosis Uncovers Novel Features, de Andrade, 2020

• Activation of Sarcolipin Expression and Altered Calcium Cycling in LMNA Cardiomyopathy, Rodriquez, 2020

• BET Bromodomain Inhibition Attenuates Cardiac Phenotype in Myocyte-Specific Lamin A/C-deficient Mice, Autuste, 2020

• Lamin A/C Cardiomyopathy With E203K Pathogenic Mutation, Sheikh, 2020

• Nuclear Filaments: Role in Chromosomal Positioning and Gene Expression, Bera, 2020

• Lamin A/C Mechanotransduction in Laminopathies, Donnaloja,2020

• Consequences of Lmna Exon 4 Mutations in Myoblast Function, Gomez-Dominguez, 2020

• Lamin A/C Cardiomyopathy with E203K Pathogenic Mutation, Sheikh, 2020

• The Laminopathies and the Insights They Provide Into the Structural and Functional Organization of the Nucleus, Wong, 2020

• Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation, Lin, 2020

• RNA Sequence Analyses throughout the Course of Mouse Cardiac Laminopathy Identify Differentially Expressed Genes for Cell Cycle, Shao, 2020, 

• Pathological Features of Lamin Cardiomyopathy, Kawano, 2020

• SYNE1-QK1 SNPs, G × G and G × E interactions on the risk of hyperlipidaemia, Zheng, 2020

• Emery-Dreifuss muscular dystrophy, Heller, 2020

• Relationship between infrared skin radiation and muscular strength tests in patients affected by Emery-Dreifuss muscular dystrophy, Cabizosu, 2020

• Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice, Mosbah, 2020

• Lamin A/C Assembly Defects in LMNA-Congenital Muscular Dystrophy Is Responsible for the Increased Severity of the Disease Compared with Emery–Dreifuss Muscular Dystrophy, Bertrand, 2020

• Loss of an H3K9me anchor rescues laminopathy-linked changes in nuclear organization and muscle function in an Emery-Dreifuss muscular dystrophy model, Harr, 2020

• The structural and gene expression hypotheses in laminopathic diseases-not so different after all, Osmanagic-Myers, 2020

• Generation of two induced pluripotent stem cell lines (FAMRCi005-A and FAMRCi005-B) from patient carrying genetic variant LMNA p.Asp357Val, Klauzen, 2020

• Refractory Right Ventricular Failure in a Patient with Emery-Dreifuss Muscular Dystrophy, Chiba, 2020

• Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Loss-of-Function Variants in Very Early-Onset Atrial Fibrillation, Perepelina, 2020

• LMNA-Related Muscular Dystrophy with Clinical Intrafamilial Variability, Cotta, 2020

• Novel candidate alleles associated with gene regulation for Emery Dreifuss muscular dystrophy, Xiong, 2020

• Research on the knockout of LMNA gene by CRISPR/Cas9 system in human cell lines, Liu, 2019

• Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies, Wahbi, 2019

• The structural and gene expression hypotheses in laminopathic diseases-not so different after all, Osmanagic-Myers, 2019

• Importance of early diagnosis in LMNA related muscular dystrophy for cardiac surveillance, Choi, 2019

• Restoration of Global Sagittal Alignment After Surgical Correction of Cervical Hyperlordosis in a Patient with Emery-Dreifuss Muscular Dystrophy: A Case Report, Diebo, 2019

• Facio-scapulo-humeral muscular dystrophy with early joint contractures and rigid spine, Papadopoulos, 2019

• Expression of Lmna-R225X nonsense mutation results in dilated cardiomyopathy and conduction disorders (DCM-CD) in mice: Impact of exercise training, Cai, 2019

• X--Linked Emery-Dreifuss Muscular Dystrophy, Viggiano, 2019

• Cardiac and Neuromuscular Features of Patients with LMNARelated Cardiomyopathy, Peretto, 2019

• A multistage sequencing strategy pinpoints novel candidate alleles for Emery-Dreifuss muscular dystrophy and supports gene misregulation as its pathomechanism, Meinke, 2019

• Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death, Yokoawa, 2019

• Emery-Dreifuss Muscular Dystrophy, Heller, 2019

• Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells, Earle, 2019

• Antepartum Diagnosis and Management of Lamin A/C Disease,  Reza, 2019

• A Novel Mutation Of The EMD Gene In A Family With Cardiac Conduction Abnormalities And A High Incidence Of Sudden Cardiac Death, Kong, 2019

• ERK1/2 Phosphorylation of FHOD Connects Signaling and Nuclear Positioning Alternations in Cardiac Laminopathy, Antoku, 2019 

• Inspiratory muscle training for advanced heart failure with lamin related muscular dystrophy, Taya, 2019

• Lamin A/C Cardiomyopathy: Implications for Treatment, Chen, 2019

• Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset, Ditaranto, 2019

• Cardiac manifestations in Emery–Dreifuss muscular dystrophy, Faiella, 2019

• Lamin A/C promotes DNA base excision repair, Maynard, 2019

• Lamin A molecular compression and sliding as mechanisms behind nucleoskeleton elasticity, Makarov, 2019

• A novel emerin gene mutation in Emery Dreifuss muscula dystrophy patient with spontaneous chordae tendinae rupture, Pancheri, 2019

• Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes, Bernasconi, 2019

• Emery Dreifuss Muscular Dystrophy, Bonne, 2019

• The importance of early diagnosis in LMNA‐related muscular dystrophy for cardiac surveillance, Choi, 2019

• Emery-Dreifuss muscular dystrophy: focal point nuclear envelope, Muchir, 2019

• Challenging the "chromatin hypothesis" of cardiac laminopathies with LMNA mutant iPS cells, Mozzetta, 2019

• Deficiency of emerin contributes differently to the pathogenesis of skeletal and cardiac muscles in LmnaH222P/H222P mutant mic, Wada, 2019

• X-linked Emery-Dreifuss muscular dystrophy manifesting with adult onset axial weakness, camptocormia, and minimal joint contractures, Brisset 2019

• Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies, Wahbi, 2019

• LMNA-Related Muscular Dystrophy with Clinical Intrafamilial Variability, Cotta, 2019

• A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes, Park, 2019

• Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy, Lee, 2019

• Identification of COMMD1 as a novel lamin A binding partner, Jiang, 2019

• Alteration of performance in a mouse model of Emery-Dreifuss muscular dystrophy caused by A-type lamins gene mutation, Thomasson, 2019

• Unweaving the role of nuclear Lamins in neural circuit integrity, Deal, 2019

• Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells, Shah, 2019

• Mutant lamins cause mechanically-induced nuclear envelope rupture, DNA damage, and DNA-PK activation in muscle, Earle, 2019

• MON129 An Unusual LMNA Mutation Causing a Complex Phenotype: When the Genetic Diagnosis Uncovers Novel Features, Andrada, 2019

• Cellular and Animal Models of Striated Muscle Laminopathies, Nicolas, 2019

• Postnatal Development of Mice with Combined Genetic Depletions of Lamin A/C, Emerin and Lamina-associated Polypeptide 1, Wang, 2019

• DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated with Lamin A/C Mutations, Chen, 2019

• Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy, Cheedipudi, 2019

• Emerin Is Required for Proper Nucleus Reassembly after Mitosis: Implications for New Pathogenetic Mechanisms for Laminopathies Detected in EDMD1 Patients, Dubinska-Magiera, 2019

• Identification of Candidate Protein Markers in Skeletal Muscle of Laminin-211-Deficient CMD Type 1A-Patients, Kolbel, 2019

• Emery Dreifuss muscular†dystrophy type 4 A new SYNE1 mutation associated with hypertrophic cardiomyopathy masked by a perinatal distress‐related† pastic diplegia, DiStolfo, 2019

• Characteristics of ventricular tachycardia and long-term treatment outcome in patients with dilated cardiomyopathy complicated by lamin A/C gene mutations, Hasebe, 2019

• Is infrared thermography (IRT) a possible tool for the evaluationand follow up of Emery-Dreifuss muscular dystrophy? Apreliminary study, Cabizosu, 2019

• Cellular and Animal Models of Striated Muscle Laminopathies, Nicolas, 2019

• The Cutting Edge: The Role of mTOR Signaling in Laminopathies, Chiarini, 2019

• Deciphering Nuclear Mechanobiology in Laminopathy, Hah, 2019

• Structural instability of lamin A tail domain modulates its assembly and higher order function in Emery-Dreifuss muscular dystrophy, Mio, 2019

• The Cutting Edge: The Role of mTOR Signaling in Laminopathies, Chiarini, 2019

• Statins and Histone Deacetylase Inhibitors Affect Lamin A/C – Histone Deacetylase 2 Interaction in Human Cells, Mattioli, 2019

• Cardiac manifestations in Emery–Dreifuss muscular dystrophy, Faiella, 2018

• SMAD6 overexpression leads to accelerated myogenic differentiation of LMNA mutated cells, Janin, 2018

• Cell signaling abnormalities in cardiomyopathy caused by Lamin AC gene mutations, Worman, 2018

• N-acetyl cysteine alleviates oxidative stress and protects mice from dilated cardiomyopathy caused by mutations in nuclear A type lamins gene, Rodriquez, 2018

• Induced Pluripotent Stem Cells to Study Mechanisms of Laminopathies: Focus on Epigenetics, Crasto, 2018

• Lamin and the heart, Capture, 2018

• The Emerging Role of Lamin C as an Important LMNA Isoform in Mechanophenotype, Gonzales-Cruz, 2018

• Cardiac Involvement in Emery-Dreifuss Muscular Dystrophy and Related Management Strategies, Wang, 2018

• The Emerging Role of Lamin C as an Important LMNA Isoform in Mechanophenotype, Gonzalez-Cruz, 2018

• Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient, Shimojima, 2018

• Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic LMNA Mutations, Steele-Stallard, 2018

• Laminopathies: The molecular background of the disease and the prospects for its treatment, Zaremba-Czogalla, 2018

• Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature, Captur, 2018

• The Pathogenesis and Therapies of Striated Muscle Laminopathies, Brull, 2018

• Assessment of fibroblast nuclear morphology aids interpretation of LMNA variants, Van Tienen, 2018

• Mouse models of nesprin-related diseases, Zhou, 2018

• Three new cases of dilated cardiomyopathy caused by mutations in LMNA gene, Sivitskaya, 2018

• Amelioration of desmin network defects by αB-crystallin overexpression confers cardioprotection in a mouse model of dilated cardiomyopathy caused by LMNA gene mutation, Gulata, 2018

• Genetic mutation of familial dilated cardiomyopathy based on nextgeneration semiconductor sequencing, 2018, Lin

• Samp1 Mislocalization in Emery-Dreifuss Muscular Dystrophy, Mattioli, 2018

• Role of Lamin A/C Gene Mutations in the Signaling Defects Leading to Cardiomyopathies, Gerbino, 2018

• Emery-Dreifuss Muscular Dystrophy-Related Myopathy with TMEM43 Mutations, Mukai, 2018

• Cardiometabolic assessment of lamin A/C gene mutation carriers: A phenotype-genotype correlation, Kwapich, 2018

• Nesprins and Lamins in Health and Diseases of Cardiac and Skeletal Muscles, Janin, 2018

• Dysfunctional lamins as mediators of oxidative stress in Emery-Dreifuss muscular dystrophy, Niebroj-Dobosz, 2018

• Complex effects of laminopathy mutations on nuclear structure and function, Ho, 2018

• Lamins and nesprin1 mediate inside out mechanical coupling in muscle cell precursors through FHOD1, Schwartz, 2018

• Single molecule analysis of lamin dynamics, Serebrvannyy, 2018

• Structural analysis of the ternary complex between lamin A/C, BAF and emerin identifies an interface disrupted in autosomal recessive progeroid diseases, Samson, 2018

• Obesity and pericallosal lipoma in Xlinked Emery Dreifuss muscular dystrophy: A case report Does Emerin play a role in adipocyte differentiation?, Spanu, 2018

• Genetics of Dilated Cardiomyopathy: Clinical Implications, Paldino, 2018

• Rescue of biosynthesis of nicotinamide adenine dinucleotide (NAD+) protects the heart in cardiomyopathy caused by lamin A/C gene mutation, Vignier, 2018

• A novel LMNA†mutation identified in a Japanese patient with LMNA associated congenital muscular dystrophy, Ishiyama, 2018

• Muscle imaging in laminopathies: synthesis study identifies meaningful muscles for follow-up, Quijano-Roy, 2018 

• Lamin A, Chromatin and FPLD2: Not Just a Peripheral Ménage-à- Trois, Briand, 2018

• Exploring the Crosstalk Between LMNA and Splicing Machinery Gene Mutations in Dilated Cardiomyopathy, Zahr, 2018

• Obesity and pericallosal lipoma in Xlinked emery dreifuss muscular dystrophy: A case report Does Emerin play a role in adipocyte differentiation?, Spanu, 2018

• Theoretical basis for a new approach of studying Emery-Dreifuss muscular dystrophy by means of thermography, Cabizosu, 2018

• Identification of a LMNA (c.646C > T) variant by whole-exome sequencing in combination with a dilated cardiomyopathy (DCM) related gene filter in a family with familiar DCM, Chen, 2018

• Plasma microRNAs as biomarkers for Lamin A/C related dilated cardiomyopathy, Toro, 2018

• Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNARelated Muscular Dystrophy, Lin, 2018

• Updated Clinical Overview on Cardiac Laminopathies: An Electrical and Mechanical Disease, Peretto, 2018

• Up-regulation of Toll-like receptors 7 and 9 and its potential implications in the pathogenic mechanisms of LMNA-related myopathies, Cappellett, 2018

• Microtubule cytoskeleton regulates connexin 43 localization and cardiac conduction in cardiomyopathy caused by mutation in Atypelamins gene, Macquart, 2018

• Muscle Magnetic Resonance Imaging in Patients with Various Clinical Subtypes of LMNA-Related Muscular Dystrophy, Lin, 2018

• Everolimus rescues multiple cellular defects in laminopathy-patient fibroblasts, Dubose, 2018

• Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutation, Chatzifrangkeskou, 2018

• Insight into the functional organization of nuclear lamins in health and disease, Tatli, 2018

• Lamins and bone disorders: current understanding and perspectives, Gargiuli, 2018

• Laminopathies; Mutations on single gene and various human genetic diseases, Kang, 2018

• OGT (O-GlcNAc Transferase) Selectively Modifies Multiple Residues Unique to Lamin A, Simon, 2018

• Three new cases of dilated cardiomyopathy caused by mutations in LMNA gene, Sivitskaya,  2018

• Cardiomyopathy with LMNA Mutation, Ito, 2018

• Risk stratification in laminopathies and Emery Dreifuss muscular dystrophy, Fayssoil, 2018

• Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects,pathophysiological hypotheses and therapeutic perspectives, Guillín-Amarelle, 2018

• Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects,pathophysiological hypotheses and therapeutic perspectives, Vigouroux, 2018

• Evidence that S6K1, but not 4E-BP1, mediates skeletal muscle pathology associated with loss of A-type lamins, Chen-Yu, 2018

• Mechanotransduction, nuclear architecture and epigenetics in Emery Dreifuss Muscular Dystrophy: tous pour un, un pour tous, Adrea, 2018

• Muscle MRI-based algorithm to differentiate inherited myopathies presenting with spinal rigidity, Tordjman, 2018

• Elevated TGF β2 serum levels in Emery-Dreifuss muscular dystrophy: implications for myocyte and tenocyte differentiationand fibrogenic processes, Bemasconi, 2018

• Correction for DuBose et al., Everolimus rescues multiple cellular defects in laminopathy-patient fibroblasts, Dubose, 2018

• Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival, Choi, 2018

• SMAD6 overexpression leads to accelerated myogenic differentiation of LMNA mutated cells, Janin, 2018.

• Clinical aspects of Emery-Dreifuss muscular dystrophy, Madej-Pilarczyk, 2018

• Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy, Messner, 2018

• A Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated Cardiomyopathy, Kawakami, 2018

• A novel feature extraction technique for pulmonary sound analysis based on EMD, Mondal, 2018

• Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy, Azibani, 2018

• Lamins and Lamin-associated Proteins in Gastrointestinal Health and Disease, Brady, 2018

• Laminopathy-causing lamin A mutations reconfigure lamina-associated domains and local spatial chromatin conformation, Briand, 2018 

• Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy, Azibani, 2018